GLAXO Share Price fell to Rs 2,991 on 01 September 2026, down 2.03% for the day, giving Glaxosmithkline Pharmaceuticals a market capitalisation of Rs 52,619.21 crore. The stock is drawing attention because the decline comes in a Large Cap pharmaceutical company that still shows premium profitability and valuation metrics versus much of its industry set.<\/p>\n
The supplied data confirms a one-session fall from the previous close of Rs 3,053.1, but it does not establish any company-specific catalyst behind the move. What the market data does show is straightforward: the stock moved lower in morning trade, turnover stood at Rs 0.24 crore, and the broader profile remains notable with a P\/E ratio of 48.42, ROE of 48.76 and ROCE of 66.79.<\/p>\n
For readers tracking GLAXO Share Price Today, the key question is not only why the stock is falling, but also whether valuation, profitability and sector positioning still justify close attention. Univest reviews the day\u2019s price action, technical context, fundamentals and peer comparison using only the available data.<\/p>\n